Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,230.12
(
0.29%
)
US TECH 100
26,942.00
(
0.87%
)
Dow Jones
49,499.27
(
-0.31%
)
Brent Oil
107.04
(
-0.07%
)
Bitcoin
78,428.70
(
-0.14%
)
News Focus
News Focus
Post# of 108195
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

sd21

Send PM Follow Ignore
Followers 1
Posts 323
Boards Moderated 0
Alias Born 12/20/2016

sd21

Re: fbg0316 post# 28596

Wednesday, 08/02/2017 10:25:06 PM

Wednesday, August 02, 2017 10:25:06 PM

Post# of 108195
Selling the company and having Amgen push trials through is the most only reasonable option. There have been TOO many delays/missteps by mgmt and bod. Bp has the experience and financial resources to make the science successful. Does the company need another CEO to make another attempt at success. After all of these years the answer is evident...SELL the company. $2B is a steal with $800m in deals and HOT + other constructs.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today